| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Pacira BioSciences, Inc.
13D/A
PCRX · 695127100
|
0% |
10/13/2026
Event 10/8/2026
|
||||
| Doma Perpetual Capital Management LLC | 0% | |||||
| DOMA1 LLC | 0% | |||||
| DOMA Perpetual LO Equity Master Fund LP | 0% | |||||
| DOMA Perpetual Partners GP LLC | 0% | |||||
| Pedro Escudero | 0% | |||||
| The John Templeton Foundation | 0% | |||||
| DOMA2 LLC | 0% | |||||
| Schedule 13G · 2 securities · passive | ||||||
|
Hingham Institution for Savings
13G/A
HIFS · 433323102
|
5.5% |
11/12/2026
Event 9/30/2026
|
||||
| Doma Perpetual Capital Management LLC | 5.5% | |||||
| DOMA1 LLC | 5.5% | |||||
| DOMA2 LLC | 5.5% | |||||
| DOMA Perpetual Partners GP LLC | 5.5% | |||||
| DOMA Perpetual LO Equity Master Fund LP | 5.5% | |||||
| Pedro Escudero | 5.5% | |||||
|
Afya Ltd
13G/A
AFYA · G01125106
|
9.3% |
11/12/2026
Event 9/30/2026
|
||||
| Doma Perpetual Capital Management LLC | 9.2% | |||||
| DOMA1 LLC | 9.2% | |||||
| DOMA2 LLC | 7.5% | |||||
| DOMA Perpetual Partners GP LLC | 7.5% | |||||
| DOMA Perpetual LO Equity Master Fund LP | 7.5% | |||||
| Pedro Escudero | 9.3% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.